UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 515

Sortiert nach

The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA

Nature reviews. Neurology, 2021-09, Vol.17 (9), p.523-524

2021

Link zum Volltext

Verfügbarkeit prüfen

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Alzheimer's & dementia, 2018-04, Vol.14 (4), p.535-562

2018

Link zum Volltext

Verfügbarkeit prüfen

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Alzheimer's & dementia, 2013-01, Vol.9 (1), p.E1-E16

2013

Link zum Volltext

Verfügbarkeit prüfen

The A4 study: stopping AD before symptoms begin?

Science translational medicine, 2014-03, Vol.6 (228), p.228fs13

2014

Link zum Volltext

Verfügbarkeit prüfen

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Journal of Nuclear Medicine, 2013-03, Vol.54 (3), p.476-490

2013

Link zum Volltext

Verfügbarkeit prüfen

The continuing unethical conduct of underpowered clinical trials

JAMA : the journal of the American Medical Association, 2002-07, Vol.288 (3), p.358

2002

Link zum Volltext

Verfügbarkeit prüfen

Functional Status, Time to Transplantation, and Survival Benefit of Kidney Transplantation Among Wait-Listed Candidates

American journal of kidney diseases, 2015-11, Vol.66 (5), p.837-845

2015

Link zum Volltext

Verfügbarkeit prüfen

Desktop medicine

JAMA : the journal of the American Medical Association, 2010-11, Vol.304 (18), p.2061

Karlawish, Jason

2010

Link zum Volltext

Verfügbarkeit prüfen

The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment

Social science & medicine (1982), 2015-10, Vol.143, p.117-127

2015

Link zum Volltext

Verfügbarkeit prüfen

Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications

JAMA : the journal of the American Medical Association, 2000-05, Vol.283 (17), p.2275

2000

Link zum Volltext

Verfügbarkeit prüfen

A pragmatist's guide to the assessment of decision-making capacity

British journal of psychiatry, 2019-04, Vol.214 (4), p.183-185

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of Playing High School Football With Cognition and Mental Health Later in Life

JAMA neurology, 2017-08, Vol.74 (8), p.909

2017

Link zum Volltext

Verfügbarkeit prüfen

Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.e106-e109

2013

Link zum Volltext

Verfügbarkeit prüfen

Cognitive, social, and neural determinants of diminished decision-making and financial exploitation risk in aging and dementia: A review and new model

Journal of elder abuse & neglect, 2016-10, Vol.28 (4-5), p.320-344

2016

Link zum Volltext

Verfügbarkeit prüfen

Fix the process that led to Alzheimer's drug fiasco

Nature (London), 2022-06, Vol.606 (7912), p.9-9

Karlawish, Jason

2022

Link zum Volltext

Verfügbarkeit prüfen

Aducanumab and the Business of Alzheimer Disease-Some Choice

JAMA neurology, 2021-11, Vol.78 (11), p.1303

Karlawish, Jason

2021

Link zum Volltext

Verfügbarkeit prüfen

What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.925-932

2018

Link zum Volltext

Verfügbarkeit prüfen

Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease

Neurology, 2011-10, Vol.77 (15), p.1487

Karlawish, Jason

2011

Link zum Volltext

Verfügbarkeit prüfen

Research Involving Cognitively Impaired Adults

The New England journal of medicine, 2003-04, Vol.348 (14), p.1389-1392

Karlawish, Jason H.T

2003

Link zum Volltext

Verfügbarkeit prüfen

Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation

PloS one, 2016-06, Vol.11 (6), p.e0156532-e0156532

2016

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer's disease: The next frontier—Special Report 2017

Alzheimer's & dementia, 2017-04, Vol.13 (4), p.374-380

2017

Link zum Volltext

Verfügbarkeit prüfen

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

PLoS medicine, 2017-03, Vol.14 (3), p.e1002254-e1002254

2017

Link zum Volltext

Verfügbarkeit prüfen

Identifying the Factors That Facilitate or Hinder Advance Planning by Persons With Dementia

Alzheimer disease and associated disorders, 2008-07, Vol.22 (3), p.293-298

2008

Link zum Volltext

Verfügbarkeit prüfen

Desktop Medicine and the Practice of Wealth Care

JAMA internal medicine, 2021-02, Vol.181 (2), p.227

Karlawish, Jason

2021

Link zum Volltext

Verfügbarkeit prüfen

Frontotemporal dementia: Clinicopathological correlations

Annals of neurology, 2006-06, Vol.59 (6), p.952-962

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 515

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(477)
Mit Volltextzugriff
(429)

Publikationsform

Sprache

Englisch
(515)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

The A4 study: stopping AD before symptoms begin?

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

The continuing unethical conduct of underpowered clinical trials

Functional Status, Time to Transplantation, and Survival Benefit of Kidney Transplantation Among Wait-Listed Candidates

Desktop medicine

The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment

Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications

A pragmatist's guide to the assessment of decision-making capacity

Association of Playing High School Football With Cognition and Mental Health Later in Life

Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education

Cognitive, social, and neural determinants of diminished decision-making and financial exploitation risk in aging and dementia: A review and new model

Fix the process that led to Alzheimer's drug fiasco

Aducanumab and the Business of Alzheimer Disease-Some Choice

What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public

Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease

Research Involving Cognitively Impaired Adults

Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation

Alzheimer's disease: The next frontier—Special Report 2017

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

Identifying the Factors That Facilitate or Hinder Advance Planning by Persons With Dementia

Desktop Medicine and the Practice of Wealth Care

Frontotemporal dementia: Clinicopathological correlations

Suchergebnisse filtern